prednisone has been researched along with Severe Acute Respiratory Syndrome in 4 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Severe Acute Respiratory Syndrome: A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayor-Ibarguren, A | 1 |
| Feito-Rodriguez, M | 1 |
| Quintana Castanedo, L | 1 |
| Ruiz-Bravo, E | 1 |
| Montero Vega, D | 1 |
| Herranz-Pinto, P | 1 |
| Avendano, M | 1 |
| Derkach, P | 1 |
| Swan, S | 1 |
| Loutfy, MR | 2 |
| Blatt, LM | 2 |
| Siminovitch, KA | 2 |
| Ward, S | 1 |
| Wolff, B | 2 |
| Lho, H | 1 |
| Pham, DH | 2 |
| Deif, H | 2 |
| LaMere, EA | 2 |
| Chang, M | 1 |
| Kain, KC | 2 |
| Farcas, GA | 2 |
| Ferguson, P | 2 |
| Latchford, M | 2 |
| Levy, G | 2 |
| Dennis, JW | 2 |
| Lai, EK | 2 |
| Fish, EN | 2 |
| Ward, SE | 1 |
| Chen, J | 1 |
| Hinek, A | 1 |
| Fung, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 Infection[NCT04344600] | Phase 2 | 6 participants (Actual) | Interventional | 2020-06-29 | Terminated (stopped due to Single center study with low enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of participants with no evidence of SARS-CoV-2 infection at or before study day 28. (NCT04344600)
Timeframe: Up to 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Peginterferon Lambda Alfa-1a | 2 |
| Placebo | 4 |
4 other studies available for prednisone and Severe Acute Respiratory Syndrome
| Article | Year |
|---|---|
Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report.
Topics: Aged, 80 and over; Biopsy, Needle; Coronavirus Infections; COVID-19; Female; Follow-Up Studies; Huma | 2020 |
Clinical course and management of SARS in health care workers in Toronto: a case series.
Topics: Adult; Anti-Bacterial Agents; Data Collection; Female; Glucocorticoids; Humans; Male; Methylpredniso | 2003 |
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents; Creatine Kinase; Drug Th | 2003 |
Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Antiviral Agents; Chemokine CCL5; Chemokine CX | 2005 |